Health-related quality of life in children with cystic fibrosis: Validation of the German CFQ-R

Health and Quality of Life Outcomes

Volumn 7, Issue , 2009, Pages

  Schmidt, Anne ^a   Wenninger, Kerstin ^b   Niemann, Nadja ^c   Wahn, Ulrich ^a   Staab, Doris ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c Physicians' Chamber of Lower Saxony   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; BODY IMAGE; CHILD; CONSTRUCT VALIDITY; CONTROLLED STUDY; CRONBACH ALPHA COEFFICIENT; CYSTIC FIBROSIS; CYSTIC FIBROSIS QUESTIONNAIRE REVISED; DIGESTIVE SYSTEM FUNCTION DISORDER; EATING DISORDER; EMOTION; FACTORIAL ANALYSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; PRESCHOOL CHILD; QUALITY OF LIFE; QUESTIONNAIRE; REPRODUCIBILITY; RESPIRATORY TRACT DISEASE; SELF CONCEPT; VALIDATION STUDY; ADULT; CUSTODY; GERMANY; HOSPITALIZATION; INSTRUMENTATION; PARENT; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; SELF EVALUATION; SEX DIFFERENCE; STANDARD;

ADOLESCENT; ADULT; CHILD; CYSTIC FIBROSIS; FEMALE; GERMANY; HUMANS; MALE; PARENTS; PROXY; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SELF ASSESSMENT (PSYCHOLOGY); SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 72549116378     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-7-97     Document Type: Article

References (47)

1. FitzSimmons SC. The changing epidemiology of cystic fibrosis. J Pediatr 1993, 122(1):1-9. 10.1016/S0022-3476(05)83478-X, 8419592.
2. Stern M, Wiedemann B, Wenzlaff P. From registry to quality management: the German Cystic Fibrosis Quality Assessment project 1995 2006. Eur Respir J 2008, 31(1):29-35. 10.1183/09031936.00056507, 17898017.
3. Abbott JHA. Measuring and reporting quality of life outcomes in clinical trials in cystic fibrosis: a critical review. Health Qual Life Outcomes 2005, 3(19).
4. Staab D, Wenninger K, Gebert N, Rupprath K, Bisson S, Trettin M, Paul KD, Keller KM, Wahn U. Quality of life in patients with cystic fibrosis and their parents: what is important besides disease severity?. Thorax 1998, 53(9):727-31. 1745310, 10319053.
5. Goss CH, Quittner AL. Patient-reported outcomes in cystic fibrosis. Proc Am Thorac Soc 2007, 4(4):378-86. 10.1513/pats.200703-039BR, 2647603, 17652505.
6. Cella DF. Quality of life: the concept. J Palliat Care 1992, 8(3):8-13.
7. Quittner AL. Measurement of quality of life in cystic fibrosis. Curr Opin Pulm Med 1998, 4(6):326-31. 10.1097/00063198-199811000-00003, 10813210.
8. Wenninger K, Aussage P, Wahn U, Staab D, . G.C.F.Q.s. group The revised German Cystic Fibrosis Questionnaire: validation of a disease-specific health-related quality of life instrument. Qual Life Res 2003, 12(1):77-85. 10.1023/A:1022011704399, 12625520.
9. Congleton J, Hodson ME, Duncan-Skingle F. Quality of life in adults with cystic fibrosis. Thorax 1996, 51(9):936-40. 10.1136/thx.51.9.936, 472619, 8984707.
10. Congleton J, Hodson ME, Duncan-Skingle F. Do Nottingham Health Profile scores change over time in cystic fibrosis?. Respir Med 1998, 92(2):268-72. 10.1016/S0954-6111(98)90107-X, 9616524.
11. Henry B, Aussage P, Grosskopf C, Goehrs JM. Development of the Cystic Fibrosis Questionnaire (CFQ) for assessing quality of life in pediatric and adult patients. Qual Life Res 2003, 12(1):63-76. 10.1023/A:1022037320039, 12625519.
12. Gee L, Abbott J, Conway SP, Etherington C, Webb AK. Development of a disease specific health related quality of life measure for adults and adolescents with cystic fibrosis. Thorax 2000, 55(11):946-54. 10.1136/thorax.55.11.946, 1745639, 11050265.
13. Goldbeck L, Schmitz TG, Henrich G, Herschbach P. Questions on life satisfaction for adolescents and adults with cystic fibrosis: development of a disease-specific questionnaire. Chest 2003, 123(1):42-8. 10.1378/chest.123.1.42, 12527601.
14. Wenninger K, Staab D, Henry B, Wahn U, . udD CFQ-Arbeitsgruppe Der Fragebogen zur Lebensqualität bei Cystischer Fibrose - Reliabilität und Validität der deutschen Adaptation. Zeitschrift für Medizinische Psychologie 1999, 3:121-128.
15. Quittner AL, Sweeny S, Watrous M, Munzenberger P, Bearss K, Gibson Nitza A, Fisher LA, Henry B. Translation and linguistic validation of a disease-specific quality of life measure for cystic fibrosis. J Pediatr Psychol 2000, 25(6):403-14. 10.1093/jpepsy/25.6.403, 10980045.
16. Quittner AL, Buu A, Messer MA, Modi AC, Watrous M. Development and validation of The Cystic Fibrosis Questionnaire in the United States: a health-related quality-of-life measure for cystic fibrosis. Chest 2005, 128(4):2347-54. 10.1378/chest.128.4.2347, 16236893.
17. Modi AC, Quittner AL. Validation of a disease-specific measure of health-related quality of life for children with cystic fibrosis. J Pediatr Psychol 2003, 28(8):535-45. 10.1093/jpepsy/jsg044, 14602844.
18. Klijn PH, van Stel HF, Quittner AL, Net J, Doeleman W, Schans C, Ent CK. Validation of the Dutch cystic fibrosis questionnaire (CFQ) in adolescents and adults. J Cyst Fibros 2004, 3(1):29-36. 10.1016/j.jcf.2003.12.006, 15463884.
19. Bregnballe V, Thastum M, Lund LD, Hansen CR, Preissler T, Schiotz PO. Validation of the Danish version of the revised cystic fibrosis quality of life questionnaire in adolescents and adults (CFQ-R14+). J Cyst Fibros 2008, 7(6):531-6. 10.1016/j.jcf.2008.06.006, 18694658.
20. Abbott J, Baumann U, Conway S, Etherington C, Gee L, Schulenburg JM, Webb K. Cross cultural differences in health related quality of life in adolescents with cystic fibrosis. Disabil Rehabil 2001, 23(18):837-44. 10.1080/09638280110072913, 11763280.
21. Tauler E, Vilagut G, Grau G, Gonzalez A, Sanchez E, Figueras G, Vall O, Ferrer M, Alonso J. The spanish version of the paediatric asthma quality of life questionnaire (PAQLQ) metric characteristics and equivalence with the original version. Qual Life Res 2001, 10(1):81-91. 10.1023/A:1016622519987, 11508478.
22. Landgraf JM. Measuring and monitoring quality of life in children and youth: A brief commentary. Sozial- und Präventivmedizin/Social and Preventive Medicine 2001, 46(5):281-282.
23. Pless IB, Nolan T. Revision, replication and neglect--research on maladjustment in chronic illness. J Child Psychol Psychiatry 1991, 32(2):347-65. 10.1111/j.1469-7610.1991.tb00312.x, 2033113.
24. Bregnballe V, Thastum M, Schiotz PO. Psychosocial problems in children with cystic fibrosis. Acta Paediatr 2007, 96(1):58-61. 10.1111/j.1651-2227.2006.00014.x, 17187605.
25. Quittner AL, Barker DH, Snell C, Grimley ME, Marciel K, Cruz I. Prevalence and impact of depression in cystic fibrosis. Curr Opin Pulm Med 2008, 14(6):582-8. 10.1097/MCP.0b013e3283121cf1, 18812836.
26. Knudson RJ, Slatin RC, Lebowitz MD, Burrows B. The maximal expiratory flow-volume curve. Normal standards, variability, and effects of age. Am Rev Respir Dis 1976, 113(5):587-600.
27. Taussig LM. Advances in cystic fibrosis: bringing the bench to the bedside. Eur J Pediatr 1995, 154(9 Suppl 4):S9-10. 10.1007/BF02191495, 8529720.
28. Cronbach L. Coefficient Alpha and the internal structure of tests. Psychometrika 1951, 16:297-333.
29. Ware JE, Brook RH, A Ross D, Williams KN, Stewart AL, Rogers WH. Conceptualization and measurement of health for adults in the Health Insurance Study. Model of health and methodology. 1980, I. Doc. no. R-1987/1-HEW. Santa Monica, CA: RAND Corporation.
30. Deyo RADP, Patrick DL. Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation. Control Clin Trials 1991, 12(4 Suppl):142S-158S. 10.1016/S0197-2456(05)80019-4, 1663851.
31. Kline P. An easy guide to factor analysis. 1994, London: Routledge.
32. Bühner. Einführung in die Test- und Fragebogenkonstruktion (Introduction to Construction of Tests and Questionnaires). 2004, Munich: Pearson Education, Studium P.
33. Juniper EF, Guyatt GH, Streiner DL, King DR. Clinical impact versus factor analysis for quality of life questionnaire construction. J Clin Epidemiol 1997, 50(3):233-8. 10.1016/S0895-4356(96)00377-0, 9120521.
34. Fayers PM, Hand DJ. Factor analysis, causal indicators and quality of life. Qual Life Res 1997, 6(2):139-50. 10.1023/A:1026490117121, 9161114.
35. Ravens-Sieberer U, Bullinger M. Assessing health-related quality of life in chronically ill children with the German KINDL: first psychometric and content analytical results. Qual Life Res 1998, 7(5):399-407. 10.1023/A:1008853819715, 9691720.
36. Arrington-Sanders R, Yi MS, Tsevat J, Wilmott RW, Mrus JM, Britto MT. Gender differences in health-related quality of life of adolescents with cystic fibrosis. Health Qual Life Outcomes 2006, 4:5. 10.1186/1477-7525-4-5, 1402258, 16433917.
37. Thomas C, Mitchell P, O'Rourke C, Wainwright C. Quality of life in children and adolescent with cystic fibrosis managed in both regional outreach and cystic fibrosis center settings in Queensland. J Pediatr 2006, 148(4):508-516. 10.1016/j.jpeds.2005.11.040, 16647415.
38. O'Connor G, Quinton H, Kahn R, Robichaud P, Maddock J, Lever T, Detzer M, Brooks J, . NNECF Consortium Case-mix adjustment for evaluation of mortality in cystic fibrosis. Pediatr Pumlonol 2002, 33(2):99-105.
39. Demko CA, Byard PJ, Davis PB. Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection. J Clin Epidemiol 1995, 48(8):1041-9. 10.1016/0895-4356(94)00230-N, 7775991.
40. Rosenfeld M, Davis R, FitzSimmons S, Pepe M, Ramsey B. Gender gap in cystic fibrosis mortality. Am J Epidemiol 1997, 145(9):794-803.
41. Riekert KA, Bartlett SJ, Boyle M, Krishnan JA, Rand CS. The association between depression, lung function, and health-related quality of life among adults with cystic fibrosis. Chest 2007, 132(1):231-7. 10.1378/chest.06-2474, 17625085.
42. Lai H-C, Kosorok MR, Laxova A, Makholm LM, Farrell PM. Delayed Diagnosis of US Females with Cystic Fibrosis. Am J Epidemiol 2002, 156(2):165-173. 10.1093/aje/kwf014, 12117708.
43. Guilbault C, Stotland P, Lachance C, Tam M, Keller A, Thompson-Snipes L, Cowley E, Hamilton T, Eidelmann D, Stevenson M, Radzioch D. Influence of gender and interleukin-10 deficiency on the inflammatory response during lung infection with Pseudomonas aeruginosa in mice. Immunology 2002, 107:297-305. 10.1046/j.1365-2567.2002.01508.x, 1782799, 12423305.
44. Landgraf JM. Measuring health-related quality of life in pediatric oncology patients: a brief commentary on the state of the art of measurement and application (discussion). Int J Cancer Suppl 1999, 12:147-50. 10.1002/(SICI)1097-0215(1999)83:12+<147::AID-IJC26>3.0.CO;2-O, 10679887.
45. Havermans T, Vreys M, Proesmans M, De Boeck C. Assessment of agreement between parents and children on health-related quality of life in children with cystic fibrosis. Child Care Health Dev 2006, 32(1):1-7. 10.1111/j.1365-2214.2006.00564.x, 16398786.
46. Elkins MR, Robinson M, Rose BR, Harbour C, Moriarty C, Marks GB, Belousova EG, Xuan W, Bye PT. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med 2006, 354(3):229-40. 10.1056/NEJMoa043900, 16421364.
47. Quittner AL, Modi AC, Wainwright C, Otto K, Kirihara J, Montgomery AB. Determination of the minimal clinically important difference scores for the Cystic Fibrosis Questionnaire-Revised respiratory symptom scale in two populations of patients with cystic fibrosis and chronic Pseudomonas aeruginosa airway infection. Chest 2009, 135(6):1610-8. 10.1378/chest.08-1190, 19447923.